To Evaluate the Efficacy and Safety of ALC-2203 in Patients With Acute Bronchitis

NCT07061925 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

169

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Bronchitis

Interventions

DRUG: ALC-2203-1
DRUG: ALC-2203-2
DRUG: ALC-2203-AC
DRUG: Placabo

Sponsor

Korea Arlico Pharm. Co., Ltd